CNW

DGAP-News: Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF(TM) from the European Medicines Agency

Thursday, October 21, 2021 - 12:09pm

An ODD brings several unique advantages, from a cost reduction in drug development, to an accelerated review process and market exclusivity for 10 years.

Key Points: 
  • An ODD brings several unique advantages, from a cost reduction in drug development, to an accelerated review process and market exclusivity for 10 years.
  • Such strategy is cost and time effective and allows the Company to easily gain market shares in a competitive free environment.
  • We firmly believe that QIXLEEF(TM) will be a safe and effective medicine for pain management and an alternative to opioids."
  • The positive opinion issued by the COMP will be sent to the European Commission, which is expected to grant the orphan designation within 30 days.

DGAP-News: Tetra Bio-Pharma Provides Update on Clinical Development Program for QIXLEEF(TM)

Thursday, October 14, 2021 - 2:29pm

Since the beginning of the clinical development program in late-2016, QIXLEEF(TM) strictly adhered to and complied with the regulatory requirements of a prescription drug.

Key Points: 
  • Since the beginning of the clinical development program in late-2016, QIXLEEF(TM) strictly adhered to and complied with the regulatory requirements of a prescription drug.
  • Having a global drug development strategy ensures economy of scale and lower cost of drug development to shareholders.
  • The REBORN(c) clinical strategy provides the fastest and lowest cost development program to bring QIXLEEF(TM) to the market.
  • Guy Chamberland, CEO and CRO commented, "Our team has made significant progress in bringing QIXLEEF(TM) to a late clinical development stage.

CannabisNewsWire to Serve as the Official Media Partner of The Cannabis Society’s Upcoming Hybrid Conferences

Friday, September 17, 2021 - 2:35pm

The conference seeks to enable participating executives to gain access to leading cannabis experts through keynotes, panel discussions and interactive workshops.

Key Points: 
  • The conference seeks to enable participating executives to gain access to leading cannabis experts through keynotes, panel discussions and interactive workshops.
  • The MSO Growth and Consolidation Conference will provide participants with direct access to leading cannabis multi-state operators (MSOs).
  • We are delighted to continue our collaboration with the CannabisNewsWire team, who will be serving as The Cannabis Societys official media partner, said Bill Hennessey, CEO of The Cannabis Society.
  • For additional details about Cannabis Societys upcoming event, including registration information, visit https://www.thecannabissociety.org .

IBN (InvestorBrandNetwork) to Serve as Media Sponsor for Roth’s Upcoming Event: Investing in Women Cannabis Pioneers Investor Conference

Tuesday, September 14, 2021 - 3:05pm

In its capacity as the events media sponsor, IBN will work towards furthering the distribution and publication of content generated for the event.

Key Points: 
  • In its capacity as the events media sponsor, IBN will work towards furthering the distribution and publication of content generated for the event.
  • Explores the challenges women face in the cannabis industry at the Board/C-Suite level, capital raising and corporate governance.
  • The panel will explore women buying patterns, product formats, targeting women, and innovation to meet the demand of the female consumer.
  • Please see full terms of use and disclaimers on the InvestorBrandNetwork website, applicable to all content provided by IBN wherever published or re-published: http://IBN.fm/Disclaimer

CannabisNewsWire Set to Serve as the Official Newswire for the Upcoming CBD Beverages & Ingestibles Summit 2021

Thursday, September 2, 2021 - 2:35pm

NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- CannabisNewsWire (CNW), a specialized communications platform for the cannabis sector and one of the 50+ brands of the InvestorBrandNetwork (IBN), is pleased to announce that it will be collaborating with Kisaco Research to serve as the official newswire for the upcoming CBD Beverages & Ingestibles Summit 2021 .

Key Points: 
  • NEW YORK, Sept. 02, 2021 (GLOBE NEWSWIRE) -- CannabisNewsWire (CNW), a specialized communications platform for the cannabis sector and one of the 50+ brands of the InvestorBrandNetwork (IBN), is pleased to announce that it will be collaborating with Kisaco Research to serve as the official newswire for the upcoming CBD Beverages & Ingestibles Summit 2021 .
  • The conference will be in Las Vegas on October 25-26, with an additional, entirely virtual session set to take place on October 12.
  • The CBD product sector is growing rapidly, with several U.S. states legalizing the sale of products containing hemp-based ingredients.
  • We are delighted to be working with the Kisaco Research team in the production of the CBD Beverages & Ingestibles Summit, said Chris Johnson, Director of Client Solutions for CannabisNewsWire.